[go: up one dir, main page]

MX2010009765A - Moleculas pequeñas que contienen boro como agentes anti-inflamatorios. - Google Patents

Moleculas pequeñas que contienen boro como agentes anti-inflamatorios.

Info

Publication number
MX2010009765A
MX2010009765A MX2010009765A MX2010009765A MX2010009765A MX 2010009765 A MX2010009765 A MX 2010009765A MX 2010009765 A MX2010009765 A MX 2010009765A MX 2010009765 A MX2010009765 A MX 2010009765A MX 2010009765 A MX2010009765 A MX 2010009765A
Authority
MX
Mexico
Prior art keywords
boron
small molecules
inflammatory agents
containing small
inflammatory
Prior art date
Application number
MX2010009765A
Other languages
English (en)
Inventor
Charles Z Ding
Jacob J Plattner
Stephen J Baker
Robert Jacobs
Kirk R Maples
Tsutomu Akama
Yong-Kang Zhang
Virginia Sanders
Yi Xia
Yvonne Freund
James A Nieman
Michael Richard Kevin Alley
Xiaosong Lu
Marcelo Sales
Rashmi Sharma
Rajeshwar Singh
Daitao Chen
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Priority claimed from PCT/US2009/036250 external-priority patent/WO2009111676A2/en
Publication of MX2010009765A publication Critical patent/MX2010009765A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/04—Esters of boric acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)

Abstract

La presente invención se refiere a compuestos y métodos para tratar condiciones anti-inflamatorias.
MX2010009765A 2008-03-06 2009-03-05 Moleculas pequeñas que contienen boro como agentes anti-inflamatorios. MX2010009765A (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US3437108P 2008-03-06 2008-03-06
US5263708P 2008-05-12 2008-05-12
US9440608P 2008-09-04 2008-09-04
US10599008P 2008-10-16 2008-10-16
US11090308P 2008-11-03 2008-11-03
US14370009P 2009-01-09 2009-01-09
US14873109P 2009-01-30 2009-01-30
PCT/US2009/036250 WO2009111676A2 (en) 2008-03-06 2009-03-05 Boron-containing small molecules as anti-inflammatory agents

Publications (1)

Publication Number Publication Date
MX2010009765A true MX2010009765A (es) 2013-07-12

Family

ID=41342554

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010009765A MX2010009765A (es) 2008-03-06 2009-03-05 Moleculas pequeñas que contienen boro como agentes anti-inflamatorios.

Country Status (12)

Country Link
US (5) US8039450B2 (es)
EP (2) EP2564857B1 (es)
KR (2) KR101672511B1 (es)
CN (1) CN102014927A (es)
AU (1) AU2009221793B2 (es)
BR (1) BRPI0908565A2 (es)
CA (1) CA2718170A1 (es)
ES (1) ES2630036T3 (es)
IL (1) IL207955A (es)
MX (1) MX2010009765A (es)
NZ (1) NZ587955A (es)
RU (2) RU2015109165A (es)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
EP1556009B2 (en) 2002-10-25 2021-07-21 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
PL1853251T3 (pl) 2005-02-16 2013-09-30 Anacor Pharmaceuticals Inc Halogenopodstawione boronoftalidy do leczenia infekcji
CN106008583A (zh) 2005-12-30 2016-10-12 安纳考尔医药公司 含硼的小分子
EP2719388B1 (en) 2006-02-16 2019-04-10 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
RU2015109165A (ru) * 2008-03-06 2015-11-10 Анакор Фармасьютикалз, Инк. Борсодержащие малые молекулы в качестве противовоспалительных агентов
WO2010028005A1 (en) * 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
EP2348863A4 (en) * 2008-09-04 2012-03-07 Anacor Pharmaceuticals Inc BORN SMALL MOLECULES
CN102223876A (zh) * 2008-09-26 2011-10-19 纳米生物公司 纳米乳剂治疗性组合物及其使用方法
WO2010045503A1 (en) * 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
AP4039A (en) 2009-08-14 2017-02-28 Daitao Chen Boron-containing small molecules as antiprotozoal agents
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9346834B2 (en) 2009-10-20 2016-05-24 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as antiprotozoal agents
US20110212918A1 (en) * 2009-11-11 2011-09-01 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2011094450A1 (en) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Boron-containing small molecules
AP2012006482A0 (en) 2010-03-19 2012-10-31 Anacor Pharmacueticals Inc Boron-containing small molecules as anti-protozoalagent
CA2776482C (en) * 2010-05-04 2022-06-07 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
LT3251678T (lt) 2010-09-07 2021-12-10 Anacor Pharmaceuticals, Inc. Benzoksaborolo dariniai, skirti bakterinių infekcijų gydymui
US9220715B2 (en) 2010-11-08 2015-12-29 Omeros Corporation Treatment of addiction and impulse-control disorders using PDE7 inhibitors
NZ610925A (en) 2010-11-08 2015-10-30 Omeros Corp Treatment of addiction and impulse-control disorders using pde7 inhibitors
EP2651407B1 (en) 2010-12-15 2016-12-21 Olatec Industries LLC 3-methanesulfonylpropionitrile for treating inflammation and pain
US8802885B2 (en) 2012-02-27 2014-08-12 Olatec Industries Llc Process for preparing 3-methylsulfonylpropionitrile
JP6178412B2 (ja) 2012-06-05 2017-08-09 オラテック セラピューティクス リミティド ライアビリティ カンパニー 炎症及び疼痛を治療するための医薬組成物
CA2875198C (en) 2012-06-11 2020-06-02 Olatec Industries Llc Compounds for treating inflammation and pain
CN104471058A (zh) * 2012-06-13 2015-03-25 弗雷德哈钦森癌症研究中心 包含硫族化物的组合物及相关方法
US9114122B2 (en) 2012-06-14 2015-08-25 Olatec Industries Llc Compounds for treating inflammation and pain
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
AU2014212576B2 (en) 2013-01-30 2015-08-13 Agrofresh Inc. Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
US9598443B2 (en) 2013-02-01 2017-03-21 Anacor Pharmaceuticals, Inc. Boron containing small molecules as antiprotozoal agents
AU2014202928B1 (en) 2013-06-05 2014-09-11 Agrofresh Inc. Compounds and compositions
TW201625649A (zh) * 2014-07-01 2016-07-16 第一三共股份有限公司 作爲抗菌劑的三環化合物
PT3261437T (pt) 2015-02-12 2019-11-29 Agrofresh Inc Compostos e composições fungicidas
WO2017031041A1 (en) * 2015-08-17 2017-02-23 Channel Therapeutics, Inc. Functionalized aminobenzoboroxoles
WO2017093857A1 (en) * 2015-11-30 2017-06-08 Anacor Pharmaceuticals, Inc. Topical pharmaceutical formulations for treating inflammatory-related conditions
NZ745681A (en) 2016-03-07 2022-05-27 Agrofresh Inc Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
WO2017193914A1 (zh) * 2016-05-09 2017-11-16 苏州科睿思制药有限公司 克立硼罗游离形式的晶型及其制备方法和用途
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
GB201701583D0 (en) * 2017-01-31 2017-03-15 Drug Delivery Solutions Ltd Topical composition
WO2018156554A1 (en) * 2017-02-21 2018-08-30 Dow Agrosciences Llc 1-HYDROXY-1,3-DIHYDROBENZO[c][1,2]OXABOROLES AND THEIR USE AS HERBICIDES
CN108864160A (zh) * 2017-05-16 2018-11-23 苏州旺山旺水生物医药有限公司 含硼小分子的制备方法
DK3630752T3 (da) 2017-06-01 2021-08-09 Bristol Myers Squibb Co Substituerede nitrogenholdige forbindelser
US20210163404A1 (en) * 2017-06-14 2021-06-03 UNIVERSITé LAVAL Novel urea compounds and bioisosteres thereof and their use for treating inflammation and inflammation-related pathologies
CN109517003A (zh) * 2017-09-18 2019-03-26 成都安满生物医药科技有限公司 一种克瑞沙硼的制备方法
MX2020005464A (es) 2017-11-30 2020-12-03 Boragen Inc Compuestos de benzoxaborol y formulaciones de los mismos.
US10329311B1 (en) 2017-12-21 2019-06-25 Olon S.P.A. Process for the preparation of crisaborole
KR101974145B1 (ko) * 2017-12-22 2019-04-30 한국생명공학연구원 보풀 추출물을 유효성분으로 함유하는 아토피 피부염의 예방, 개선 또는 치료용 조성물
CN108148085B (zh) * 2018-01-04 2019-11-01 合肥医工医药股份有限公司 具有抑制磷酸二酯酶4的化合物、制法及其药物用途
CN108047261B (zh) * 2018-01-10 2020-12-18 苏州旺山旺水生物医药有限公司 一种克立硼罗的制备方法
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
CN108546245A (zh) * 2018-05-22 2018-09-18 绍兴文理学院 一种抗增殖活性中间体ml-098的制备方法
GB201809378D0 (en) * 2018-06-07 2018-07-25 Glaxosmithkline Ip Dev Ltd Novel compounds
CN108997394A (zh) * 2018-06-12 2018-12-14 广州百霆医药科技有限公司 苯并氧杂硼杂环戊烷类化合物及其制备方法
CN108997399A (zh) * 2018-07-24 2018-12-14 武汉轻工大学 克立硼罗中间体的制备方法
ES3039445T3 (en) * 2018-07-31 2025-10-21 Mc2 Therapeutics Ltd Topical composition
MX2021001904A (es) * 2018-08-18 2021-05-27 Boragen Inc Formas solidas de benzoxaborol sustituido y composiciones de las mismas.
CU20210023A7 (es) * 2018-10-05 2021-10-12 Pfizer Inhibidores fenil sustituidos de la piridinil 1,2-oxaborolan-2-ol fosfodiesterasa 4
DK3952995T3 (da) * 2019-04-12 2023-10-30 Riboscience Llc Bicykliske heteroarylderivater som ectonukleotidpyrophosphatase-phosphodiesterase-1-hæmmere
EP3969458A4 (en) 2019-05-13 2023-05-17 Borah, Inc. CHEMICAL COMPOUNDS
WO2021003501A1 (en) * 2019-07-03 2021-01-07 Boragen, Inc. Chemical compounds
AR120504A1 (es) 2019-11-22 2022-02-16 Agrofresh Inc Composición y método para tratar a plantas y partes de plantas con activos volátiles para el control de organismos de descomposición
KR102334997B1 (ko) * 2019-11-27 2021-12-03 한국화학연구원 보풀 속 식물 추출물을 유효성분으로 포함하는 구강질환 또는 골질환의 예방 또는 치료용 조성물
IL295239A (en) 2020-02-05 2022-10-01 Agrofresh Inc Antimicrobial compounds and preparations
MX2022013657A (es) 2020-05-05 2023-02-01 Nuvalent Inc Quimioterápicos de éter macrocíclico heteroaromático.
WO2021226269A1 (en) 2020-05-05 2021-11-11 Nuvalent, Inc. Heteroaromatic macrocyclic ether chemotherapeutic agents
CN111595974A (zh) * 2020-05-30 2020-08-28 山东希尔康泰药业有限公司 罗氟司特原料药的分析方法
CN113801089B (zh) * 2020-06-15 2024-03-15 鲁南制药集团股份有限公司 一种克立硼罗中间体的制备方法
CA3202251A1 (en) * 2020-12-25 2022-06-30 Zhongli WANG Borate derivative and uses thereof
CN114685537A (zh) * 2020-12-28 2022-07-01 南京理工大学 丁苯酞衍生物g-3702在制备脑缺血再灌注损伤预防和治疗药物中的应用
RU2756250C1 (ru) * 2021-02-04 2021-09-28 Федеральное бюджетное учреждение науки «Екатеринбургский медицинский-научный центр профилактики и охраны здоровья рабочих промпредприятий» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ЕМНЦ ПОЗРПП Роспотребнадзора) Способ повышения устойчивости организма к цитотоксическому действию кристаллического диоксида кремния
CN113387971B (zh) * 2021-04-19 2023-10-27 安徽普利药业有限公司 克立硼罗的合成方法
EP4408844A1 (en) 2021-10-01 2024-08-07 Nuvalent, Inc. Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds
TW202404610A (zh) 2022-06-24 2024-02-01 大陸商瑞石生物醫藥有限公司 一種硼酸酯衍生物的結晶、其製備方法及用途
CN120230131A (zh) * 2023-12-31 2025-07-01 上海鼎雅药物化学科技有限公司 4-[(1,3-二氢-1-羟基-2,1-苯并氧杂硼杂环戊烷-5-基)氧基]苯甲腈的制备方法
CN119285528B (zh) * 2024-12-11 2025-05-09 济南大学 一种1,2-环戊二甲酰亚胺的合成方法

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2260336A (en) 1939-10-16 1941-10-28 Dow Chemical Co Method of preparation of organic borates
US3686398A (en) 1970-07-20 1972-08-22 Chevron Res 10,9-boroxarophenanthrene as fungicides
GB1396904A (en) 1972-08-11 1975-06-11 Ici Ltd Method for the control of micro-organisms
US4602011A (en) 1975-10-24 1986-07-22 Chapman Chemical Company Antimicrobial compositions and methods of using same
US4766113A (en) 1975-10-24 1988-08-23 Chapman Chemical Company Antimicrobial compositions and methods of using same
US5169637A (en) 1983-03-24 1992-12-08 The Liposome Company, Inc. Stable plurilamellar vesicles
CA1237671A (en) 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
US4716035A (en) 1985-05-24 1987-12-29 The Procter & Gamble Company Oral compositions and methods for treating gingivitis
US5409704A (en) 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
US4975282A (en) 1985-06-26 1990-12-04 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
US5023087A (en) 1986-02-10 1991-06-11 Liposome Technology, Inc. Efficient method for preparation of prolonged release liposome-based drug delivery system
US5962498A (en) 1986-06-11 1999-10-05 Procyon Pharmaceuticals, Inc. Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
IE60901B1 (en) 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US5049388A (en) 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US4894220A (en) 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
US5032582A (en) 1987-02-27 1991-07-16 Liposome Technology, Inc. Method for treating fungal infections with amphotericin B/cholesterol sulfate composition
US4994213A (en) 1988-05-17 1991-02-19 Liposome Technology, Inc. Method of preparing lipid structures
US4919934A (en) 1989-03-02 1990-04-24 Richardson-Vicks Inc. Cosmetic sticks
US5194266A (en) 1989-08-08 1993-03-16 Liposome Technology, Inc. Amphotericin B/cholesterol sulfate composition and method
US5356633A (en) 1989-10-20 1994-10-18 Liposome Technology, Inc. Method of treatment of inflamed tissues
DK0580817T3 (da) 1991-04-19 1996-08-05 Nexstar Pharmaceuticals Inc Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
SG47101A1 (en) 1992-07-31 1998-03-20 Us Bioscience Crystalline amifostine compositions and methods for the preparation and use of same
US5552155A (en) 1992-12-04 1996-09-03 The Liposome Company, Inc. Fusogenic lipsomes and methods for making and using same
US5348948A (en) 1993-05-07 1994-09-20 American Cyanamid Company 2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
US5348947A (en) 1993-05-07 1994-09-20 American Cyanamid Company Diarylboron ester and thioester fungicidal agents
US5594151A (en) 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexing reagents derived from aminosalicylic acid
GB9411587D0 (en) 1994-06-09 1994-08-03 Zeneca Ltd Compound, composition and use
US6083903A (en) 1994-10-28 2000-07-04 Leukosite, Inc. Boronic ester and acid compounds, synthesis and uses
GB9500856D0 (en) 1995-01-17 1995-03-08 Zeneca Ltd Composition and use
WO1996040061A1 (en) 1995-06-07 1996-12-19 Nexstar Pharmaceuticals, Inc. Method for encapsulating pharmaceutical materials
WO1998024753A1 (en) 1996-12-02 1998-06-11 Chisso Corporation Optically active nitro alcohol derivatives, optically active amino alcohol derivates, and process for preparing the same
GB9604926D0 (en) 1996-03-08 1996-05-08 Sandoz Ltd Organic compounds
EP0934307B1 (en) 1996-06-19 2011-04-27 Aventis Pharma Limited Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
US5831046A (en) 1996-08-05 1998-11-03 Prolinx, Incorporated Boronic acid-contaning nucleic acid monomers
WO1998012206A1 (en) 1996-09-19 1998-03-26 The Board Of Trustees Of Leland Stanford Jr. University Dna adenine methyltransferases and uses thereof
US6221640B1 (en) 1997-05-14 2001-04-24 Cubist Pharmaceuticals, Inc. Enterococcal aminoacyl-trna synthetase proteins, nucleic acids and strains comprising same
DE19829947A1 (de) 1998-07-04 2000-01-05 Bayer Ag Elektrolumineszierende Anordnungen mit Bor-Chelaten
US6462036B1 (en) 1998-11-06 2002-10-08 Basf Aktiengesellschaft Tricyclic pyrazole derivatives
SK5282001A3 (en) 1998-11-06 2002-01-07 Knoll Gmbh Tricyclic pyrazole derivatives
WO2000044387A1 (fr) 1999-01-29 2000-08-03 Nitto Kasei Co., Ltd. Composes organobores presentant une activite de coccidiostats
AU774404C (en) 1999-05-25 2005-06-30 Board Of Trustees Of The Leland Stanford Junior University DNA methyltransferase inhibitors
US6306628B1 (en) 1999-08-25 2001-10-23 Ambergen, Incorporated Methods for the detection, analysis and isolation of Nascent proteins
ATE349548T1 (de) 1999-08-25 2007-01-15 Ambergen Inc Verfahren zur erkennung, analyse und isolierung von freiwerdenden proteinen
WO2001025226A1 (en) 1999-10-05 2001-04-12 Bethesda Pharmaceuticals, Inc. Dithiolane derivatives
EP1250142A4 (en) 2000-01-06 2007-07-11 Marantech Holding Llc ADDED COMPOSITIONS WITH ELECTRONIC ELECTRODES AND METHOD FOR THE PRODUCTION AND USE THEREOF
US6521619B2 (en) 2000-06-29 2003-02-18 Icos Corporation Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents
US7169603B2 (en) 2000-07-14 2007-01-30 Mgi Pharma Biologics, Inc. α-MSH related compounds and methods of use
EP1339725B1 (en) 2000-11-30 2006-11-22 The Penn State Research Foundation Dna methyl transferase inhibitors
US6537733B2 (en) * 2001-02-23 2003-03-25 Applied Materials, Inc. Method of depositing low dielectric constant silicon carbide layers
DE10110051C2 (de) 2001-03-02 2003-07-03 Clariant Gmbh Verfahren zur Herstellung von Boron- und Borinsäuren
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
GB0117645D0 (en) 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10143979A1 (de) 2001-09-07 2003-03-27 Clariant Gmbh Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
US7217701B2 (en) 2001-10-11 2007-05-15 Katsuhiko Mikoshiba Intracellular calcium concentration increase inhibitors
CN1325504C (zh) 2002-01-10 2007-07-11 宾夕法尼亚州研究基金会 制备二芳基硼酸烷基酯和络合的二芳基硼酸的方法
AU2003265264A1 (en) 2002-07-09 2004-01-23 Point Therapeutics, Inc. Methods and compositions relating to isoleucine boroproline compounds
US20050288299A1 (en) 2002-10-09 2005-12-29 Mavunkel Babu J Azaindole derivatives as inhibitors of p38 kinase
JP2006508161A (ja) 2002-12-02 2006-03-09 ソルヴィーアス　アクチェンゲゼルシャフト 炭素−ヘテロ原子二重結合の接触水素化
US20040224923A1 (en) 2002-12-18 2004-11-11 Ving Lee Antibiotics containing borinic acid complexes and methods of use
US7390806B2 (en) 2002-12-18 2008-06-24 Anacor Pharmaceuticals, Inc. Antibiotics containing borinic acid complexes and methods of use
US20050125852A1 (en) 2003-05-09 2005-06-09 Sugen, Inc. Novel kinases
CA2529792A1 (en) 2003-06-16 2005-02-17 Anacor Pharmaceuticals, Inc. Hydrolytically-resistant boron-containing therapeutics and methods of use
US10022424B2 (en) 2004-05-12 2018-07-17 The Brigham And Women's Hospital, Inc. Use of gelsolin to treat infections
AR049915A1 (es) 2004-06-14 2006-09-13 Anacor Pharmaceuticals Inc Compuestos con contenido de boro y metodos de uso de los mismos
WO2006062731A1 (en) 2004-11-19 2006-06-15 University Of North Texas Health Science Center At Fort Worth Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye
GB0501944D0 (en) 2005-01-31 2005-03-09 Univ Cambridge Tech Compounds for use in chemical detection and/or quantitation
PL1853251T3 (pl) * 2005-02-16 2013-09-30 Anacor Pharmaceuticals Inc Halogenopodstawione boronoftalidy do leczenia infekcji
WO2006096131A1 (en) 2005-03-08 2006-09-14 Agency For Science, Technology And Research Chiral bisoxazoline catalysts
PE20061303A1 (es) 2005-03-30 2006-12-07 Astion Dev As Composicion farmaceutica que comprende oxaprozina
US20080234229A1 (en) * 2005-08-18 2008-09-25 Auspex Pharmaceuticals, Inc. Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders
CN106008583A (zh) 2005-12-30 2016-10-12 安纳考尔医药公司 含硼的小分子
EP2719388B1 (en) * 2006-02-16 2019-04-10 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
AU2007257689A1 (en) 2006-06-12 2007-12-21 Anacor Pharmaceuticals, Inc. Compounds for the treatment of periodontal disease
US20070286822A1 (en) 2006-06-12 2007-12-13 Anacor Pharmaceuticals Inc. Compounds for the Treatment of Periodontal Disease
KR100848491B1 (ko) 2007-01-16 2008-07-28 영진약품공업주식회사 베타아미노기를 갖는 2-싸이아졸리딘 유도체, 이의약학적으로 허용 가능한 염 및 이의 제조 방법
JO3396B1 (ar) 2007-06-20 2019-10-20 Anacor Pharmaceuticals Inc جزيئات صغيرة تحتوي على البورون
KR100895300B1 (ko) 2007-07-20 2009-05-07 한국전자통신연구원 생체신호 측정의복과 생체신호 처리시스템
EP2187893A4 (en) 2008-03-06 2012-02-22 Anacor Pharmaceuticals Inc SMALL BORON-CONTAINING MOLECULES AS ANTI-INFLAMMATORY AGENTS
RU2015109165A (ru) * 2008-03-06 2015-11-10 Анакор Фармасьютикалз, Инк. Борсодержащие малые молекулы в качестве противовоспалительных агентов
US20100256092A1 (en) 2008-05-12 2010-10-07 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010028005A1 (en) 2008-09-04 2010-03-11 Anacor Pharmaceuticals, Inc. Boron-containing small molecules
WO2010045503A1 (en) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-protozoal agents
WO2010045505A1 (en) 2008-10-15 2010-04-22 Anacor Pharmaceuticals, Inc Boron-containing small molecules as anti-protozoal agents

Also Published As

Publication number Publication date
AU2009221793B2 (en) 2015-02-19
KR20110000739A (ko) 2011-01-05
EP2564857A1 (en) 2013-03-06
IL207955A (en) 2015-05-31
CA2718170A1 (en) 2009-09-11
US9012431B2 (en) 2015-04-21
EP3246034A1 (en) 2017-11-22
US20120214765A1 (en) 2012-08-23
US20150291629A1 (en) 2015-10-15
US9416146B2 (en) 2016-08-16
KR20150065941A (ko) 2015-06-15
EP2564857B1 (en) 2017-05-03
CN102014927A (zh) 2011-04-13
BRPI0908565A2 (pt) 2017-05-23
US8461135B2 (en) 2013-06-11
NZ587955A (en) 2012-10-26
AU2009221793A1 (en) 2009-09-11
US20090291917A1 (en) 2009-11-26
ES2630036T3 (es) 2017-08-17
RU2547441C2 (ru) 2015-04-10
KR101672511B1 (ko) 2016-11-03
RU2015109165A (ru) 2015-11-10
RU2010140803A (ru) 2012-04-20
US8039450B2 (en) 2011-10-18
US20160318955A1 (en) 2016-11-03
US20140011768A1 (en) 2014-01-09
IL207955A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
MX2010009765A (es) Moleculas pequeñas que contienen boro como agentes anti-inflamatorios.
WO2009111676A3 (en) Boron-containing small molecules as anti-inflammatory agents
MX360301B (es) Moleculas pequeñas que contienen boro como agentes antiinflamatorios.
GB0920703D0 (en) Compositions containing satiogens and methods of use
JO2788B1 (en) Amido phenoxyendazole compounds beneficial as C-MET inhibitors
PH12012502128B1 (en) Chemical compounds
IN2012DN03883A (es)
MX2011006290A (es) Compuestos de aza-azuleno.
JO2860B1 (en) Phenylendazolyl compounds
SG148142A1 (en) Aryloazol-2-yl cyanoethylamino compunds, method of making and method of using thereof
WO2012034116A3 (en) Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders
MX2009009761A (es) Composiciones y estuches para tratamiento de la influenza.
MX2010010209A (es) 4-hidroxipirimidina-5-carboxamidas sustituidas.
IL206970A0 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
MX2012012966A (es) Indoles.
EA201170832A1 (ru) Пуриновые соединения
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
MX2010005395A (es) Metodo para tratar artritis.
BR112012003111A8 (pt) Métodos para tratar iontoforeticamente náusea e enxaqueca
MX2011013878A (es) 4-hidroxipirimidina-5-carboxamidas sustituidas.
EP2597949A4 (en) SUBMIKROMETERZUSAMMENSETZUNGEN
MX2011013879A (es) 4-hidroxipirimidina-5-carboxamidas sustituidas.
UA34487U (en) Aquananomagnesium
UA101379C2 (en) Amidophenoxyindazoles useful in the treatment of cancer
TN2011000013A1 (en) Amidophenoxyindazoles useful as inhibitors of c-met

Legal Events

Date Code Title Description
FG Grant or registration